Melanoma News and Research RSS Feed - Melanoma News and Research

Melanoma is a form of cancer that begins in melanocytes (cells that make the pigment melanin). It may begin in a mole (skin melanoma), but can also begin in other pigmented tissues, such as in the eye or in the intestines.
ACS approves $1.7 million funding for new research grants to Yale University

ACS approves $1.7 million funding for new research grants to Yale University

The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has approved funding for three new research grants totaling over $1.7 million to investigators at Yale University. [More]
New optical fibre probe can help surgeons detect breast cancer tissue during surgery

New optical fibre probe can help surgeons detect breast cancer tissue during surgery

Working with excised breast cancer tissue, researchers from the University of Adelaide developed the device to differentiate cancerous cells from healthy ones. [More]
UC San Diego scientists reveal surprising role for Hippo pathway in subduing tumor immunogenicity

UC San Diego scientists reveal surprising role for Hippo pathway in subduing tumor immunogenicity

Previous studies identified the Hippo pathway kinases LATS1/2 as a tumor suppressor, but new research led by University of California San Diego School of Medicine scientists reveals a surprising role for these enzymes in subduing cancer immunity. The findings, published in Cell on December 1, could have a clinical role in improving efficiency of immunotherapy drugs. [More]
Alcohol consumption linked to higher risk of melanoma

Alcohol consumption linked to higher risk of melanoma

Alcohol intake was associated with higher rates of invasive melanoma among white men and women. [More]
Scientists synthesize antitumor compound to combat chemoresistant cancer

Scientists synthesize antitumor compound to combat chemoresistant cancer

A team of scientists from N. D. Zelinsky Institute of Organic Chemistry of the Russian Academy of Sciences, N. K. Kol'tsov Institute of Developmental Biology of the RAS, and Immune Pharmaceuticals LLC led by MIPT's Prof. Alexander Kiselyov has synthesized an antitumor compound that could be used to fight chemoresistant cancer. [More]
New optical fiber probe could help differentiate between healthy and cancerous tissue during surgery

New optical fiber probe could help differentiate between healthy and cancerous tissue during surgery

An optical fiber probe can distinguish cancer tissue and normal tissue at the margins of a tumor being excised, in real time, by detecting the difference in pH between the two types of tissue. [More]
Melanoma drug offers considerable added benefit for patients with advanced NSCLC

Melanoma drug offers considerable added benefit for patients with advanced NSCLC

Pembrolizumab was initially introduced for the treatment of melanoma. Since July 2016, the monoclonal antibody has also been available for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in adults whose tumours express the T-cell receptor ligand PD-L1 and who have received a prior chemotherapy regimen. [More]
Researchers call sun avoidance as emerging health problem in the U.S.

Researchers call sun avoidance as emerging health problem in the U.S.

A landmark study published Friday in the Journal Dermato-Endocrinology has world-renowned researchers calling insufficient sun exposure an emerging health problem in the United States. [More]
New public-private partnership launches major health effort to reduce cancer in San Francisco

New public-private partnership launches major health effort to reduce cancer in San Francisco

Cancer is the leading cause of death in San Francisco and costs patients, families and taxpayers hundreds of millions of dollars each year. [More]
New study describes role of protein that is crucial for melanoma cell survival

New study describes role of protein that is crucial for melanoma cell survival

The main goals of the Melanoma Group at the Spanish National Cancer Research Centre are to identify biomarkers of tumour progression and to validate novel therapeutic targets in melanoma. [More]
GW researchers awarded $2.2 million NCI grant to study role of HERVs in cancer

GW researchers awarded $2.2 million NCI grant to study role of HERVs in cancer

George Washington University researchers received a $2.2 million grant from the National Cancer Institute to uncover why certain cancer types increase whereas others are unchanged or even decrease in those with HIV infection. [More]
NYU Langone cancer expert honored with 2016 "Giants of Cancer Care" Award

NYU Langone cancer expert honored with 2016 "Giants of Cancer Care" Award

Jeffrey S. Weber, MD, PhD, deputy director of NYU Langone's Perlmutter Cancer Center, has received a 2016 "Giants of Cancer Care" Award. [More]
Virginia Tech and CytImmune Sciences develop more effective and less toxic cancer treatment

Virginia Tech and CytImmune Sciences develop more effective and less toxic cancer treatment

Virginia Tech scientists have developed a new cancer drug that uses gold nanoparticles created by the biotech firm CytImmune Sciences to deliver paclitaxel — a commonly used chemotherapy drug directly to a tumor. [More]
TSRI study suggests new approach to limit tumor growth by targeting immune system cells

TSRI study suggests new approach to limit tumor growth by targeting immune system cells

A new study led by scientists at The Scripps Research Institute suggests there may be a way to limit tumor growth by targeting immune system cells called macrophages. [More]
Moffitt scientists show how mathematical modeling can predict patient responses to cancer drugs

Moffitt scientists show how mathematical modeling can predict patient responses to cancer drugs

Scientists have significantly improved their understanding of cancer and have developed numerous therapies that have helped to reduce patient mortality; however, the majority of drugs that make it to the clinical trial phase of development fail, despite promising data in laboratory studies. [More]
Scientists identify genetic mutations in highly aggressive rhabdoid meningiomas

Scientists identify genetic mutations in highly aggressive rhabdoid meningiomas

Meningiomas are the most common primary brain tumors, but the term encompasses over a dozen subtypes that range from benign to highly aggressive. [More]
Study shows many indoor tanning facilities comply with Texas under-18 ban

Study shows many indoor tanning facilities comply with Texas under-18 ban

When female employees of a mystery shopping firm called posing as 17-year-olds interested in tanning, 81 percent of indoor tanning facilities complied with the Texas ban on indoor tanning for those under the age of 18 in a study conducted by The University of Texas MD Anderson Cancer Center. [More]
Ludwig study shows how experimental drug can reverse effects of suppressive immune cells

Ludwig study shows how experimental drug can reverse effects of suppressive immune cells

A Ludwig Cancer Research study shows that an experimental drug currently in clinical trials can reverse the effects of troublesome cells that prevent the body's immune system from attacking tumors. [More]

Person's risk factor status may help tailor surveillance program for melanomas, study suggests

The new study, published online today by JAMA Dermatology, identifies high risk patients who may benefit from tailored surveillance. [More]
Dermatologists offer tips to help men develop healthy skin care routines

Dermatologists offer tips to help men develop healthy skin care routines

When it comes to skin care, men have traditionally kept it simple. However, experts say more men are now pursuing healthier, younger-looking skin. [More]
Advertisement